- Home
- MSGE vs ADPT Comparison
MSGE vs ADPT Comparison
Compare MSGE & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGE
- ADPT
- Stock Information
- Founded
- MSGE 2020
- ADPT 2009
- Country
- MSGE United States
- ADPT United States
- Employees
- MSGE N/A
- ADPT N/A
- Industry
- MSGE Services-Misc. Amusement & Recreation
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MSGE Consumer Discretionary
- ADPT Health Care
- Exchange
- MSGE Nasdaq
- ADPT Nasdaq
- Market Cap
- MSGE 1.4B
- ADPT 1.4B
- IPO Year
- MSGE N/A
- ADPT 2019
- Fundamental
- Price
- MSGE $37.25
- ADPT $9.55
- Analyst Decision
- MSGE Strong Buy
- ADPT Buy
- Analyst Count
- MSGE 6
- ADPT 6
- Target Price
- MSGE $49.83
- ADPT $9.83
- AVG Volume (30 Days)
- MSGE 256.3K
- ADPT 1.8M
- Earning Date
- MSGE 05-06-2025
- ADPT 05-01-2025
- Dividend Yield
- MSGE N/A
- ADPT N/A
- EPS Growth
- MSGE 157.00
- ADPT N/A
- EPS
- MSGE 2.72
- ADPT N/A
- Revenue
- MSGE $974,670,000.00
- ADPT $189,527,000.00
- Revenue This Year
- MSGE $0.42
- ADPT $25.00
- Revenue Next Year
- MSGE $6.30
- ADPT $20.38
- P/E Ratio
- MSGE $13.66
- ADPT N/A
- Revenue Growth
- MSGE 5.81
- ADPT 8.61
- 52 Week Low
- MSGE $28.29
- ADPT $2.99
- 52 Week High
- MSGE $44.14
- ADPT $10.28
- Technical
- Relative Strength Index (RSI)
- MSGE 60.63
- ADPT 60.50
- Support Level
- MSGE $36.43
- ADPT $8.50
- Resistance Level
- MSGE $37.30
- ADPT $9.69
- Average True Range (ATR)
- MSGE 0.73
- ADPT 0.42
- MACD
- MSGE -0.20
- ADPT -0.00
- Stochastic Oscillator
- MSGE 37.10
- ADPT 81.40
About MSGE Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).